Inozyme Pharma Inc reports results for the quarter ended in March - Earnings Summary

Inozyme Pharma

10/05/2022 15:17

* Inozyme Pharma Inc  INZY.OQ  reported a quarterly adjusted
loss
of 71 cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 82
cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Inozyme Pharma Inc's reported EPS for the quarter was a
loss
of 71 cents​.
    * The mean earnings estimate of analysts had fallen by
about 24.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Inozyme Pharma Inc shares had fallen by 9.8% this
quarter and
lost 45.9% so far this year.
    * The company reported a quarterly loss of $16.88 million.
    * Wall Street's median 12-month price target for Inozyme
Pharma
Inc is $26.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 02:17 p.m.  ​All
figures in US dollars unless otherwise stated